Since the recent findings give the objectives to consider autophagy-stimulating therapy as a prerequisite for successful therapy of psychiatric disorders, irisin appears as a prototypic molecule that can activate autophagy with therapeutic goals. Here, FNDC5 is linked to psychiatric disorder.